FDA issues 510(k) clearance for Implicity’s SignalHF1 algorithm
The Implicity’s SignalHF1 algorithm can predict heart failure risks using data from cardiac devices.
The Implicity’s SignalHF1 algorithm can predict heart failure risks using data from cardiac devices.
The companies will integrate Medis Medical’s non-invasive coronary physiology test, Medis QFR, with GE HealthCare’s cardiology Allia Platform.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Profound wins FDA clearance for AI support to Tulsa system
FDA warns users not to use Cue Health’s at-home Covid-19 tests
Industry takes: the importance of keeping healthcare businesses cybersecure
Skin in the game: the latest issue of Medical Technology is out now